EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transapical mitral valve-in-ring implantation: Results of the real-world European Tendyne valve-in-ring registry

Julian Maier, Hendrik Ruge, Markus Krane, Sabine Bleiziffer, Kai P Friedrichs, Efstratios I Charitos, Markus Schönburg, Elmar W Kuhn, Cristina Giannini, Marco De Carlo, Rui Campante Teles, Tiago Nolasco und 9 weitere

Clinical Research in Cardiology · 04.11.2026

DOI: 10.1007/s00392-026-03039-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 04.11.2026. Verfasst von Julian Maier und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kepler University Hospital, Krankenhausstraße 9, 4020, Linz, Austria. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johannes Kepler University Linz.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Mitral regurgitation (MR) is commonly treated with ring-based annuloplasty. In case of recurrent MR, re-do operations are often denied due to high risk. Transcatheter valve-in-ring (V-i-R) procedures offer an alternative. This study assessed the feasibility and outcomes of using the transapical, repositionable Tendyne valve for off-label mitral V-i-R procedures, as an alternative to balloon-expandable valves like SAPIEN, which face limitations such as paravalvular leakage and LVOT obstruction.

Methods

The TEND-RING registry is a retrospective, international study with prospective follow-up, including 16 high-risk patients from eight European centers who underwent Tendyne V-i-R procedures between 2017 and 2024. Procedural, 30-day, and long-term outcomes were analyzed.

Results

Patients were elderly (median age 79.5), predominantly male (81%), with significant comorbidities (STS Risk of Mortality 5.6%, 4.4–7.2%) and severe MR (3 + /4 +). Procedural success was 100%, with no LVOT obstruction or device embolization. MR was reduced to mild or none in all patients. 30-day mortality was 6.3%. Over a median 11-month follow-up, five deaths occurred (31.3%), three from cardiovascular causes (18.75%). Surviving patients showed sustained MR reduction and improved symptoms (89% in NYHA I/II). Ring size analysis suggested a minimum of 36 mm for rigid/semi-rigid rings, while flexible bands allowed successful implantation in sizes as small as 30 mm.

Conclusions

Tendyne V-i-R procedures are technically feasible, effective, and safe in selected high-risk patients with recurrent MR. Ring size thresholds identified may guide patient selection and procedural planning in future interventions.

Schlagwörter

Stichwörter der Autor:innen

Transcatheter mitral valve replacementV-i-RValve-in-ring

Autor:innen und Institutionen

  • Department of Cardiology, Kepler University Hospital, Krankenhausstraße 9, 4020, Linz, Austria.
  • Clinical Research Institute for Cardiovascular and Metabolic Diseases, Medical Faculty, Johannes Kepler University Linz, Altenberger Straße 69, 4040, Linz, Austria.
  • Department of Cardiovascular Surgery, TUM School of Medicine and Health, Technical University of Munich, TUM University Hospital German Heart Center, Lazarettstraße 36, 80636, Munich, Germany.
  • Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Ruhr University Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Germany.
  • Department of General and Interventional Cardiology-Angiology, Heart and Diabetes Center NRW, Ruhr University Bochum, Georgstr. 11, 32545, Bad Oeynhausen, Germany.
  • Department of Cardiac Surgery, Kerckhoff Heart Center, Benekestr. 2-8, 61231, Bad Nauheim, Germany.

Förderung

  • Johannes Kepler University Linz

Zitieren

APA

Maier, J., Ruge, H., Krane, M., Bleiziffer, S., Friedrichs, K. P., Charitos, E. I., Schönburg, M., Kuhn, E. W., Giannini, C., De Carlo, M., Teles, R. C., Nolasco, T., Andreas, M., Zillner, L., Blessberger, H., Lambert, T., Damian, I., Grund, M., Zierer, A. F., …, & Kellermair, J. (2026). Transapical mitral valve-in-ring implantation: Results of the real-world European Tendyne valve-in-ring registry. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-026-03039-6

Vancouver

Maier J, Ruge H, Krane M, Bleiziffer S, Friedrichs KP, Charitos EI, et al. Transapical mitral valve-in-ring implantation: Results of the real-world European Tendyne valve-in-ring registry. Clinical Research in Cardiology. 2026. doi:10.1007/s00392-026-03039-6

BibTeX
@article{Maier2026,
  author = {Maier, Julian and Ruge, Hendrik and Krane, Markus and Bleiziffer, Sabine and Friedrichs, Kai P and Charitos, Efstratios I and Schönburg, Markus and Kuhn, Elmar W and Giannini, Cristina and De Carlo, Marco and Teles, Rui Campante and Nolasco, Tiago and Andreas, Martin and Zillner, Liliane and Blessberger, Hermann and Lambert, Thomas and Damian, Ilinca and Grund, Michael and Zierer, Andreas F and Steinwender, Clemens and Kellermair, Jörg},
  title = {Transapical mitral valve-in-ring implantation: Results of the real-world European Tendyne valve-in-ring registry},
  journal = {Clinical Research in Cardiology},
  year = {2026},
  doi = {10.1007/s00392-026-03039-6}
}
Kostenlos starten →